Bearish flow noted in Seattle Genetics with 5,623 puts trading, or 3x expected. Most active are Oct-23 190 puts and Oct-23 160 puts, with total volume in those strikes near 2,700 contracts. The Put/Call Ratio is 35.36, while ATM IV is up over 1 point on the day. Earnings are expected on November 2nd.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SGEN:
- Seagen, Genmab announce Phase 3 innovaTV 301 trial met primary endpoint of OS
- Biotech Alert: Searches spiking for these stocks today
- Seagen says ‘OS, data, a secondary endpoint, are not yet mature’
- Seagen: TUKYSA trial in combo with Kadcyla meets primary endpoint of PFS
- Pfizer Stock’s (NYSE:PFE) Future: Not as Bleak as You’d Think
